Back to Authors

Rees, William

Mayo Clinic

From the Service de Neurologie Sclérose en Plaques (R.M.), Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, France; University of Colorado School of Medicine (J.L.B.), Anschutz Medical Campus

Citations 1

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

Neurology Neuroimmunology & Neuroinflammation | March 26, 2021 | Volume: 8 | Issue: 3 | Pages: No page available

10.1212/nxi.0000000000000978 | PMID 33771837